Skip to main content Skip to navigation

The Cancer Treatment And Research Trust CIO

Support research in medical oncology.

Email Charity

Activities & Mission

Support research in medical oncology.

Areas of Operation

Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.

Financial Information

Latest Income
£502,151
Latest Expenditure
£142,202

Financial Efficiency

Program Ratio 27.3%
% of income going directly to charitable activities
Overall Efficiency 96.4%
% of expenditure going to programs (vs overhead)
Administrative Ratio 39.7%
Overhead (fundraising + governance) as % of total expenditure

Latest Financial Breakdown

Income Sources

Donations & Legacies £425,326
Charitable Activities £44,426
Other Trading £14,809
Investments £17,590
Other Income £0

Expenditure Categories

Charitable Expenditure £137,094
Raising Funds £5,108
Governance £51,323
Grants to Institutions £0
Other Expenditure £0

Financial Trend

Annual Returns

As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2024.

One or more years show a significant change in income (over ±100%) compared with the prior year. This usually reflects a merger, transfer of activities, restated accounts, or a one-off legacy — not necessarily a real change in operating scale. See the methodology for context.

Financial YearIncomeExpenditureCharitable SpendingNet AssetsReservesStaff
2024
£502,151
£142,202£137,094£1,545,418£1,200,0002 / 2
2023
£179,738
£223,0420 / 2
2022
£381,840
£202,5070 / 0
2021
£0
£00 / 0

Staff column shows: Employees / Volunteers

Frequently asked questions about The Cancer Treatment And Research Trust CIO

What does The Cancer Treatment And Research Trust CIO do?

Support research in medical oncology.

How much income did The Cancer Treatment And Research Trust CIO report in 2024?

The Cancer Treatment And Research Trust CIO reported total income of £502k and reported expenditure of £142k for the financial year ending 2024, based on the most recent annual return filed with the Charity Commission.

When was The Cancer Treatment And Research Trust CIO registered as a charity?

The Cancer Treatment And Research Trust CIO was registered with the Charity Commission for England and Wales on 27 May 2021 as charity number 1194608. It has been registered for 5 years.

Who runs The Cancer Treatment And Research Trust CIO?

The Cancer Treatment And Research Trust CIO is governed by a board of 9 trustees. The chair of trustees is Professor Michael Julian Seckl PhD. Trustees are legally responsible for the charity's governance and are listed in full on its profile.

Where does The Cancer Treatment And Research Trust CIO operate?

The Cancer Treatment And Research Trust CIO operates across 3 areas: Northern Ireland, Scotland and England And Wales.

Is The Cancer Treatment And Research Trust CIO a registered charity?

Yes — The Cancer Treatment And Research Trust CIO is a registered charity in England and Wales, charity number 1194608.

Details

Address
Upper East Research Office
Mount Vernon Hospital
Rickmansworth Road
Northwood
Middlesex
HA6 2RN
Registration Date
27 May 2021
Status
Registered

Registry Information

Organisation Number
5166676
Charity Number
1194608

Is this your charity?

Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.

Claim this listing Learn more about premium profiles

Trustees

Professor Michael Julian Seckl PhD Chair
Also governs 1 other charity
Dr Anand Sharma
Also governs 1 other charity
Dr David James Pinato
Also governs 1 other charity
Dr Ehsan Ghorani
Glen Williams
Kirandeep Kaur Grewal
Also governs 1 other charity
PROFESSOR GORDON JOHN SAMPSON RUSTIN
Also governs 2 other charities
Professor PAUL DANIEL NATHAN
Also governs 1 other charity
Russell John Hallam
Also governs 1 other charity

Data & trust

Register data refreshed
30 July 2026
Report a data issue